ArticleNature communications2024

KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Yong Yean Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.